David A. Decker

2.6k total citations
57 papers, 1.8k citations indexed

About

David A. Decker is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, David A. Decker has authored 57 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 22 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in David A. Decker's work include Breast Cancer Treatment Studies (8 papers), Brain Metastases and Treatment (6 papers) and Cancer Treatment and Pharmacology (6 papers). David A. Decker is often cited by papers focused on Breast Cancer Treatment Studies (8 papers), Brain Metastases and Treatment (6 papers) and Cancer Treatment and Pharmacology (6 papers). David A. Decker collaborates with scholars based in United States, United Kingdom and Germany. David A. Decker's co-authors include Ishmael Jaiyesimi, Gabriel N. Hortobagyi, Aman U. Buzdar, Hal G. Bingham, Cynthia Kresge, Muhyi Al‐Sarraf, Frank A. Vicini, Veronica Decker, Barbara Given and Alla Sikorskii and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Cancer.

In The Last Decade

David A. Decker

55 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David A. Decker United States 20 853 474 360 325 285 57 1.8k
Geert H. Blijham Netherlands 21 989 1.2× 523 1.1× 227 0.6× 175 0.5× 423 1.5× 48 2.1k
Brigitte Trétarre France 29 972 1.1× 527 1.1× 286 0.8× 152 0.5× 385 1.4× 122 2.5k
Adnan Aydıner Türkiye 25 1.0k 1.2× 473 1.0× 295 0.8× 127 0.4× 361 1.3× 156 2.3k
Juan Lin United States 26 812 1.0× 526 1.1× 360 1.0× 156 0.5× 279 1.0× 138 3.0k
Douglas E. Merkel United States 18 1.2k 1.4× 430 0.9× 675 1.9× 201 0.6× 255 0.9× 26 2.2k
Eliezer Robinson Israel 29 924 1.1× 819 1.7× 261 0.7× 144 0.4× 481 1.7× 113 2.4k
Matthew Burnell United Kingdom 25 1.1k 1.3× 500 1.1× 260 0.7× 651 2.0× 453 1.6× 66 3.3k
Shari Goldfarb United States 26 1.3k 1.5× 387 0.8× 169 0.5× 210 0.6× 289 1.0× 96 3.1k
Mark S. Walker United States 26 855 1.0× 572 1.2× 193 0.5× 128 0.4× 207 0.7× 121 2.1k
P.F. Bruning Netherlands 21 1.3k 1.5× 311 0.7× 522 1.4× 238 0.7× 111 0.4× 55 2.2k

Countries citing papers authored by David A. Decker

Since Specialization
Citations

This map shows the geographic impact of David A. Decker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Decker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Decker more than expected).

Fields of papers citing papers by David A. Decker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Decker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Decker. The network helps show where David A. Decker may publish in the future.

Co-authorship network of co-authors of David A. Decker

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Decker. A scholar is included among the top collaborators of David A. Decker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Decker. David A. Decker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Decker, David A., Lisa Collier, Tsz Lau, et al.. (2016). The Effects of Clinically Relevant Hypertonic Saline and Conivaptan Administration on Ischemic Stroke. Acta neurochirurgica. Supplementum. 121. 243–250. 6 indexed citations
2.
Litherland, Sally A., Robert B. Reynolds, Louis H. Barr, Alvin J.O. Almodovar, & David A. Decker. (2015). Abstract P4-01-15: Assay Development for detection of estrogen responsive gene histone acetylation in breast cancer circulating tumor cells. Cancer Research. 75(9_Supplement). P4–1. 1 indexed citations
3.
Lawson, Matthew F., et al.. (2010). Acute Intraprocedural Thrombus Formation During Wingspan Intracranial Stent Placement for Intracranial Atherosclerotic Disease. Operative Neurosurgery. 67(3). ons166–ons170. 14 indexed citations
4.
Decker, David A. & James J. Galligan. (2010). Molecular mechanisms of cross‐inhibition between nicotinic acetylcholine receptors and P2X receptors in myenteric neurons and HEK‐293 cells. Neurogastroenterology & Motility. 22(8). 901–901. 14 indexed citations
6.
Sikorskii, Alla, Charles W. Given, Barbara Given, et al.. (2007). Symptom Management for Cancer Patients: A Trial Comparing Two Multimodal Interventions. Journal of Pain and Symptom Management. 34(3). 253–264. 84 indexed citations
7.
Blacker, Charla M., et al.. (2005). Study of Sexual Functioning Determinants in Breast Cancer Survivors. The Breast Journal. 11(6). 440–447. 143 indexed citations
8.
9.
Stromberg, Jannifer, et al.. (2002). Acute and Subacute Toxicity Associated with Concurrent Adjuvant Radiation Therapy and Paclitaxel in Primary Breast Cancer Therapy. The Breast Journal. 8(3). 149–153. 79 indexed citations
10.
Decker, David A., et al.. (1997). Hormone replacement therapy in breast cancer survivors. Maturitas. 28(1). 90–90. 1 indexed citations
11.
Decker, David A., et al.. (1996). Naturally fractured tight gas reservoir detection optimization: Piceance Basin. The Leading Edge. 15(8). 947–948. 6 indexed citations
12.
Decker, David A.. (1995). Naturally fractured tight gas reservoir detection optimization. University of North Texas Digital Library (University of North Texas). 1 indexed citations
13.
Mattson, Joan C., et al.. (1995). Separate clones in concomitant multiple myeloma and a second B‐cell neoplasm demonstrated by molecular and immunophenotypic analysis. European Journal Of Haematology. 54(4). 254–261. 18 indexed citations
14.
Decker, David A., et al.. (1991). Local Tissue Reaction to Intravenous Fluorouracil and Leucovorin. DICP. 25(3). 249–250. 1 indexed citations
15.
Decker, David A., et al.. (1987). Pilot Study of Combination 5-Fluorouracil, Cisdiamminedichloroplatinum II, and Radiation Therapy for Grade III and IV Astrocytomas. American Journal of Clinical Oncology. 10(5). 444–447. 10 indexed citations
16.
Decker, David A., et al.. (1984). Brain metastases in patients with renal cell carcinoma: prognosis and treatment.. Journal of Clinical Oncology. 2(3). 169–173. 92 indexed citations
17.
Decker, David A., et al.. (1981). High-Dose Methotrexate with a Safe Rescue Program. Oncology. 38(5). 262–264. 1 indexed citations
18.
Rubin, Joseph, et al.. (1980). An Evaluation of Two Schedules of VP-16 and Adriamycin in Patients with Advanced Breast Cancer. Oncology. 37(3). 149–151. 10 indexed citations
19.
Decker, David A.. (1979). Complete Responders to Chemotherapy in Metastatic Breast Cancer. JAMA. 242(19). 2075–2075. 48 indexed citations
20.
Decker, David A. & Richard W. Fincham. (1971). Respiratory Arrest in Myasthenia Gravis With Colistimethate Therapy. Archives of Neurology. 25(2). 141–144. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026